The impact of co-morbidity on the quality of life of people with dementia: findings from the IDEAL study
Sharon M. Nelis(University of Exeter), Linda Clare(University of Exeter), Yu‐Tzu Wu(Newcastle University), Anthony Martyr(University of Exeter), Roy Jones(Royal United Hospital), Catherine Quinn(University of Exeter), Jennifer Rusted(University of Sussex), John V. Hindle(University of Exeter), Fiona E. Matthews(Hull York Medical School), Michael D. Kopelman(King's College London), Isla Rippon(Brunel University of London), Jeanette M. Thom(The University of Sydney)
Cited by 119
Related Papers
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
|New England Journal of Medicine|2012|774
The changing prevalence and incidence of dementia over time — current evidence
|Nature Reviews Neurology|2017|773
Rehabilitation of executive functioning: An experimental–clinical validation of Goal Management Training
|Journal of the International Neuropsychological Society|2000|654
White Matter Lesions in an Unselected Cohort of the Elderly
|Stroke|2006|590
On the path to 2025: understanding the Alzheimer’s disease continuum
|Alzheimer s Research & Therapy|2017|559